Efficacy and safety of co-administered once-weekly cagrilintide 2.4 mg with once-weekly semaglutide 2.4 mg in type 2 diabetes: a multicentre, randomised, double-blind, active-controlled, phase 2 trial
For many women in perimenopause or menopause, these moments spark real concern: Is this normal
A 2024 double-blind randomized trial of 156 participants with early Parkinsons disease found that participants receiving a GLP-1 drug, lixisenatide, showed no progression of motor symptoms, compared to a measurable worsening on standard motor scales in the placebo group
Microneedle-Mediated Delivery of Copper Peptide Through Skin
This measure aims to make evidence-based treatments more accessible for public servants, reduce long-term healthcare costs, and promote a healthier state workforce
Thats where antioxidants step in, the molecular defence system that helps your body reset and repair